Novak Rodger

Company

Date

Role

Action

Shares

Amount

Of holding

CRSP CRISPR Therapeutics AG

30 Jun 2021

President

Sold, plan not stated

25,000

$4.13M

4.2%

CRSP CRISPR Therapeutics AG

28 Jun 2021

President

Sold, plan not stated

25,000

$3.91M

4.0%

CRSP CRISPR Therapeutics AG

21 Jun 2021

President

Sold, plan not stated

25,000

$3.22M

3.9%

CRSP CRISPR Therapeutics AG

30 Nov 2020

President

Sold, plan not stated

100,000

$12.50M

13.4%

CRSP CRISPR Therapeutics AG

9 Oct 2020

President

Sold, plan not stated

2,762

$276.20K

0.4%

CRSP CRISPR Therapeutics AG

8 Oct 2020

President

Sold, plan not stated

22,238

$2.22M

3.3%

CRSP CRISPR Therapeutics AG

1 Sep 2020

President

Sold, plan not stated

25,000

$2.32M

3.7%

CRSP CRISPR Therapeutics AG

19 Aug 2020

President

Sold, plan not stated

25,000

$2.50M

3.7%

CRSP CRISPR Therapeutics AG

7 Jul 2020

President

Sold, plan not stated

25,000

$2.25M

3.7%

CRSP CRISPR Therapeutics AG

1 Jul 2020

President

Sold, plan not stated

50,000

$4.00M

7.2%

CRSP CRISPR Therapeutics AG

23 Jun 2020

President

Sold, plan not stated

50,000

$3.75M

6.7%

CRSP CRISPR Therapeutics AG

26 May 2020

President

Sold, plan not stated

36,616

$2.57M

4.7%

CRSP CRISPR Therapeutics AG

22 May 2020

President

Sold, plan not stated

13,384

$937.01K

1.7%

CRSP CRISPR Therapeutics AG

19 May 2020

President

Sold, plan not stated

50,000

$3.25M

5.9%

CRSP CRISPR Therapeutics AG

19 Nov 2019

President

Sold, plan not stated

33,618

$2.35M

100%

CRSP CRISPR Therapeutics AG

10 Jul 2019

President

Sold, plan not stated

50,000

$2.50M

5.6%

CRSP CRISPR Therapeutics AG

10 Jun 2019

President

Sold, plan not stated

50,000

$2.25M

5.3%

CRSP CRISPR Therapeutics AG

4 Mar 2019

President

Sold, plan not stated

76,527

$3.10M

7.5%

CRSP CRISPR Therapeutics AG

1 Mar 2019

President

Sold, plan not stated

8,693

$347.80K

0.8%

CRSP CRISPR Therapeutics AG

25 Feb 2019

President

Sold, plan not stated

14,780

$591.23K

1.4%

CRSP CRISPR Therapeutics AG

9 Jan 2019

President

Sold, plan not stated

82,690

$2.89M

7.3%

CRSP CRISPR Therapeutics AG

8 Jan 2019

President

Sold, plan not stated

17,310

$607.41K

1.5%

CRSP CRISPR Therapeutics AG

17 May 2018

President

Sold, plan not stated

75,000

$4.50M

6.1%

CRSP CRISPR Therapeutics AG

5 Sep 2017

Chief Executive Officer

Sold, plan not stated

3,853

$78.32K

0.3%

CRSP CRISPR Therapeutics AG

31 Aug 2017

Chief Executive Officer

Sold, plan not stated

14,617

$305.07K

1.3%

CRSP CRISPR Therapeutics AG

30 Aug 2017

Chief Executive Officer

Sold, plan not stated

58,103

$1.18M

4.8%

CRSP CRISPR Therapeutics AG

28 Aug 2017

Chief Executive Officer

Sold, plan not stated

17,692

$354.92K

1.4%

CRSP CRISPR Therapeutics AG

22 Jun 2017

Chief Executive Officer

Sold, plan not stated

10,825

$166.39K

0.9%

CRSP CRISPR Therapeutics AG

21 Jun 2017

Chief Executive Officer

Sold, plan not stated

11,578

$173.85K

0.9%

CRSP CRISPR Therapeutics AG

20 Jun 2017

Chief Executive Officer

Sold, plan not stated

3,252

$48.78K

0.3%

CRSP CRISPR Therapeutics AG

19 Jun 2017

Chief Executive Officer

Sold, plan not stated

15,392

$230.88K

1.3%

CRSP CRISPR Therapeutics AG

9 Jun 2017

Chief Executive Officer

Sold, plan not stated

1,100

$16.58K

0.1%

CRSP CRISPR Therapeutics AG

8 Jun 2017

Chief Executive Officer

Sold, plan not stated

4,203

$63.05K

0.3%

CRSP CRISPR Therapeutics AG

30 May 2017

Chief Executive Officer

Sold, plan not stated

3,650

$54.83K

0.3%

CRSP CRISPR Therapeutics AG

17 May 2017

Chief Executive Officer

Sold, plan not stated

25,923

$415.58K

2.1%

CRSP CRISPR Therapeutics AG

16 May 2017

Chief Executive Officer

Sold, plan not stated

24,077

$397.28K

1.9%

CRSP CRISPR Therapeutics AG

5 May 2017

Chief Executive Officer

Sold, plan not stated

616

$10.43K

0.1%

CRSP CRISPR Therapeutics AG

4 May 2017

Chief Executive Officer

Sold, plan not stated

13,191

$215.96K

1.1%

CRSP CRISPR Therapeutics AG

3 May 2017

Chief Executive Officer

Sold, plan not stated

20,269

$325.99K

1.6%

CRSP CRISPR Therapeutics AG

2 May 2017

Chief Executive Officer

Sold, plan not stated

15,924

$263.24K

1.3%

CRSP CRISPR Therapeutics AG

20 Apr 2017

Chief Executive Officer

Sold, plan not stated

2,294

$39.85K

0.2%

CRSP CRISPR Therapeutics AG

19 Apr 2017

Chief Executive Officer

Sold, plan not stated

47,706

$854.07K

3.8%